Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 21, Number 10—October 2015
Research

Epidemiology of Lyme Disease, Nova Scotia, Canada, 2002–2013

Todd F. HatchetteComments to Author , B. Lynn Johnston, Emily Schleihauf, Angela Mask, David Haldane, Michael Drebot, Maureen Baikie, Teri Cole, Sarah Fleming, Richard Gould, and Robbin Lindsay
Author affiliations: Nova Scotia Health Authority, Halifax, Nova Scotia, Canada (T.F. Hatchette, B.L. Johnston, D. Haldane); Dalhousie University, Halifax (T.F. Hatchette, B.L. Johnston, D. Haldane); Public Health Agency of Canada, Ottawa, Ontario, Canada (E. Schleihauf, A. Mask); Public Health Agency of Canada, Winnipeg, Manitoba, Canada (M. Drebot, R. Lindsay) Government of Nunavut, Iqaluit, Nunavut, Canada (M. Baikie); Nova Scotia Department of Health and Wellness, Halifax (T.J. Cole, S. Fleming); York Region Public Health, Newmarket, Ontario, Canada (R. Gould)

Main Article

Table 2

Characteristics of 329 reported LD case-patients, Nova Scotia Canada, 2002–2013*

Characteristic No. (%)
Sex
M 200 (60.8)
F
129 (39.2)
Age group, y
0–9 31 (9.4)
10–19 33 (10.0)
20–29 17 (5.2)
30–39 17 (5.2)
40–49 32 (9.7)
50–59 67 (20.4)
60–69 76 (23.1)
70–79 44 (13.4)
>80
12 (3.6)
Case definition met
Confirmed 241 (73.3)
Probable
EM with history of exposure to endemic 
region 66 (20.1)
Clinical evidence of illness without exposure 
to endemic region with laboratory evidence
22 (6.7)
Symptom†
Rash, any reported 295 (89.7)
Influenza-like illness 229 (69.6)
EM, physician-diagnosed 175 (53.2)
Recurrent brief episodes of large joint swelling 77 (23.4)
Bell palsy 23 (7.0)
Nervous system symptoms, excluding Bell 
palsy 21 (6.4)
Cardiovascular system signs
4 (1.2)
History of tick bite
Definite 87 (26.4)
Possible, exposure to wooded or brushy 
regions 199 (60.5)
Unknown
43 (13.1)
DHA of residence‡
DHA 1 235 (71.4)
DHA 2 21 (6.4)
DHA 3 9 (2.7)
DHA 4 4 (1.2)
DHA 5 1 (0.3)
DHA 6 8 (2.4)
DHA 7 4 (1.2)
DHA 8 2 (0.6)
DHA 9
45 (13.7)
Hospitalized 13 (4.0)

*Endemic regions as defined in June 2014. Some cases classified to exposure retrospectively (i.e., case occurred before endemic region were declared). DHA, District Health Authority; EM, erythema migrans; LD, Lyme disease.
†More than 1 symptom might be reported per case-patient. Rash, any reported, includes EM. Cardiovascular system signs include atrioventricular block, mycarditis, other.
‡DHA 1, endemic regions declared in 2003 and 2012; DHA 2, endemic regions declared in 2008 and 2011; DHA 6, endemic region declared in 2010; DHA 9, endemic region declared in 2006.

Main Article

Page created: September 22, 2015
Page updated: September 22, 2015
Page reviewed: September 22, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external